Efgartigimod alfa and hyaluronidase-qvfc (subcutaneously)

Efgartigimod alfa and hyaluronidase-qvfc (subcutaneously)

Efgartigimod alfa and hyaluronidase-qvfc (subcutaneously)

Used for efgartigimod alfa and hyaluronidase-qvfc

This medicine should only be administered by or under your doctor's direct supervision.

Before using efgartigimod alfa and hyaluronidase-qvfc

When deciding whether to use a medicine, the risks of taking the medicine must be weighed against the benefits it produces. This is a decision that you and your doctor will make. The following should be noted with this medicine:

Allergies

Tell your doctor if you have ever had an unusual or allergic reaction to this medicine or any other medicines. Also tell your doctor if you have other allergies, such as to foods, dyes, preservatives or animals. For over-the-counter products, read the label or package ingredients carefully.

Pediatrics

No appropriate studies have been conducted on the relationship between age and the effects of efgartigimod alfa and hyaluronidase-qvfc combination injection in children and adolescents. Safety and effectiveness have not been established.

geriatrics

Related studies conducted to date have not shown any geriatric-specific problems that would limit the benefit of efgartigimod alfa and hyaluronidase-qvfc combination injection in the elderly.

Breastfeeding

There are insufficient studies in women to determine the risk to infants when using this drug while breast-feeding. Weigh the potential benefits against the potential risks before taking this medication while breastfeeding.

Drug interactions

Although certain medicines should not be used together at all, in other cases two different medicines can be used together, although interactions may occur. In these cases, your doctor may want to change the dose or other precautions may be necessary. Tell your doctor if you are taking other prescription or nonprescription (over-the-counter [OTC]) medicine.

Interactions with food/tobacco/alcohol

Certain medicines should not be taken during or near food or consumption of certain foods because interactions may occur. Consuming alcohol or tobacco with certain medications can also lead to interactions. Discuss using your medicine with food, alcohol or tobacco with your doctor.

Other medical problems

The presence of other medical problems may affect the use of this medicine. Be sure to tell your doctor if you have any other medical problems, especially:

• Infektion, Vorgeschichte: Kann die Fähigkeit Ihres Körpers, Infektionen zu bekämpfen, beeinträchtigen.

Proper use of efgartigimod alfa and hyaluronidase-qvfc

A nurse or other trained health professional will give you this medicine in a medical facility. It is given as an injection under the skin in the stomach area. It is usually given once a week for 4 weeks.

Missed dose

Call your doctor or pharmacist for instructions.

Precautions when using efgartigimod alfa and hyaluronidase-qvfc

It is very important that your doctor check your progress at regular visits to make sure this medicine is working properly. Blood tests may be needed to check for adverse effects.

Call your doctor immediately if you experience a cough that does not go away, weight loss, night sweats, fever, chills, flu-like symptoms (e.g., runny or stuffy nose, headache, blurred vision, or generally feeling unwell). , painful or difficult urination or sores, ulcers or white patches in the mouth or lips. These may be signs that you have an infection.

This medicine can cause serious allergic reactions, including angioedema, which can be life-threatening and require immediate medical attention. Tell your doctor immediately if you experience a large, hive-like swelling of the face, eyelids, lips, tongue, throat, hands, legs, feet, or genital organs, skin itching, rash, or difficulty breathing after using this medication.

While you are being treated with Efgartigimod alfa and hyaluronidase-qvfc combination injection, you must not have any vaccinations (vaccines) without your doctor's approval. Live vaccines should not be administered with the combination of efgartigimod alfa and hyaluronidase-qvfc.

Do not take any other medicines unless you have discussed this with your doctor. This includes both prescription and nonprescription (over-the-counter [OTC]) medications and herbal or vitamin supplements.

Side effects of efgartigimod alfa and hyaluronidase-qvfc

In addition to the necessary effects, a medicine may also have some undesirable effects. Although not all of these side effects may occur, medical attention may be required if they occur.

Contact your doctor or nurse immediately if any of the following side effects occur:

More common

• Blasenschmerzen
• blutiger oder trüber Urin
• Husten
• schwieriges, brennendes oder schmerzhaftes Wasserlassen
• Schwierigkeiten beim Bewegen
• Fieber
• häufiger Harndrang
• Gelenkschmerzen
• Schmerzen im unteren Rücken oder an der Seite
• Muskelschmerzen, Krämpfe, Schmerzen oder Steifheit
• niesen
• Halsentzündung
• geschwollene Gelenke

Incident not known

• Schwierigkeiten beim Atmen oder Schlucken
• schneller Herzschlag
• Große, bienenstockartige Schwellung im Gesicht, an Augenlidern, Lippen, Zunge, Hals, Händen, Beinen, Füßen oder Geschlechtsorganen
• Juckreiz, Hautausschlag oder Rötung der Haut
• Schwellung von Gesicht, Rachen oder Zunge
• Atembeschwerden

Some side effects may occur that usually do not require medical attention. These side effects may disappear during treatment as your body gets used to the medicine. Your doctor may also be able to give you ways to prevent or reduce some of these side effects. If any of the following side effects persist or are bothersome, or if you have any questions, contact your doctor:

More common

• Brennen, Krabbeln, Jucken, Taubheitsgefühl, Kribbeln, „Ameisenlaufen“ oder Kribbeln
• Kopfschmerzen

Some patients may also experience other side effects not listed. If you notice other side effects, contact your doctor.

Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088.

Commonly used brand names

In the USA

• Vyvgart Hytrulo

Available dosage forms:

• Lösung

Therapeutic class: Immunological agent

Pharmacological class: Human hyaluronidase, recombinant

More information